Welcome to our dedicated page for Tenet Healthcare SEC filings (Ticker: THC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Reading Tenet Healthcare’s disclosures can feel like triaging a busy emergency room—hundreds of pages, three operating segments, and intricate Medicare rules pack every document. Whether you need Tenet Healthcare insider trading Form 4 transactions or the cash-flow detail buried in the Tenet Healthcare quarterly earnings report 10-Q filing, raw EDGAR text alone slows decisions.
Stock Titan’s AI quickly converts that overload into plain language. Our engine delivers Tenet Healthcare SEC filings explained simply, highlighting hospital occupancy swings, ambulatory surgery center margins, and Conifer Health Solutions revenue trends. Get push alerts for Tenet Healthcare Form 4 insider transactions real-time, one-click access to management’s risk commentary, and contextual charts that transform numbers into insight.
Use cases investors rely on:
- Compare segment EBITDAR across periods with Tenet Healthcare earnings report filing analysis.
- Answer board questions by understanding Tenet Healthcare SEC documents with AI instead of skimming 300 pages.
- Monitor sentiment via Tenet Healthcare executive stock transactions Form 4 before earnings calls.
The platform covers every form in real time. The Tenet Healthcare annual report 10-K simplified section surfaces payer-mix tables and litigation reserves; the Tenet Healthcare proxy statement executive compensation view breaks down incentive targets; and Tenet Healthcare 8-K material events explained flags sudden divestitures or ASC acquisitions within minutes. From first-read AI summaries to full PDF text, every filing is one search away—so you can focus on diagnosing value, not decoding jargon.
Tenet Healthcare (THC) Form 144 summary: An insider filed a notice to sell 8,000 common shares through Fidelity Brokerage Services on or about 08/20/2025. The filing lists an aggregate market value of $1,436,278.72 and total shares outstanding of 88,351,000, meaning the proposed sale equals approximately 0.0091% of outstanding shares. All 8,000 shares were acquired by restricted stock vesting from the issuer as compensation on dates in 2023 and 2024 (658; 1,088; 3,946; 2,308). The filer reports no securities sold in the past three months and makes the required representation about lack of undisclosed material information.
Tenet Healthcare exec Sun Park had 20,707 restricted stock units (RSUs) convert into common stock on 08/13/2025 after a relocation-based vesting condition was met. The RSUs convert one-for-one into common shares, bringing Park's post-transaction direct beneficial ownership to 23,392 shares. To cover taxes on vesting, 8,813 shares were withheld at an effective value of $171.87 per share, leaving 14,579 shares retained. The RSUs were originally granted on July 17, 2023 under the 2019 Stock Incentive Plan and exercised via standard vesting mechanics.
Saumya Sutaria, CEO and director of Tenet Healthcare Corporation (THC), received a grant of 106,682 shares of common stock that vested as performance-based restricted stock on 08/13/2025. The filing states the award was earned after the Human Resources Committee certified achievement of performance targets for the period January 1, 2021 to June 30, 2025. Following the transaction, Sutaria beneficially owns 475,365 shares. The Form 4 was signed by an attorney-in-fact on 08/15/2025.
FAQ
What is the current stock price of Tenet Healthcare (THC)?
What is the market cap of Tenet Healthcare (THC)?
